Health Canada is concealing routine drug company research cited as justification for new regulations on over-the-counter sales of a common painkiller. The department said Canadians would have to file Access To Information requests for the study, though it’s part of public consultations: “You give and they take”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
